Skip to content
value.today

NxPHASE Medical, Inc.

Total raised
$60 M
2 rounds on record
Latest round
$40 M
Dec 2024
First round on record
Sep 2021
Today
Private
No later event on record

Funding rounds

2 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of NxPHASE Medical, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Dec 2024$40 MNo. 2$10 to $50 million

NxPHASE Medical, Inc.: Raise no. 2, Dec 2024

Investors in this round

16 investors had bought by the notice of Dec 31, 2024: 16 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$40 M of $80 M offered; $40 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
$625,000
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks finders' fees as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael Kujak · Executive Officer, Director
  • Andre de Bruin · Director
  • Andrew Cleeland · Director
  • David Adair · Director
  • Jan Garfinkle · Director
  • Michael Hoey · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the use of proceeds: “Excludes standard compensation for officers and directors”

Signed by Michael Kujak, President and CEO. Newest notice filed Dec 31, 2024. Read the notice at the SEC.

equitySEC
Sep 2021$20 MNo. 1$10 to $50 million

NxPHASE Medical, Inc.: Raise no. 1, Sep 2021

Investors in this round

18 investors had bought by the notice of Sep 29, 2021: 18 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$20 M of $55 M offered; $35 M still to sell
Smallest investment taken
$79,385
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael Kujak · Executive Officer, Director
  • Andre de Bruin · Director
  • David Adair · Director
  • Jan Garfinkle · Director
  • Michael Hoey · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Michael Kujak, President and Chief Executive Officer. Newest notice filed Sep 29, 2021. Read the notice at the SEC.

equitySEC
Nov 2018$10 MIssued in a merger or acquisition$10 to $50 million

NxPHASE Medical, Inc.: Private sale, Nov 2018

Investors in this round

14 investors had bought by the notice of Nov 29, 2018: 14 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $18 M offered; $8 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, other: Series A Preferred Stock
Exemption claimed
  • Rule 504(b)(1)(iii): under a state exemption for accredited investors
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Michael Hoey · Executive Officer, Director
  • Michael Kujak · Executive Officer, Director
  • Andre de Bruin · Director
  • David Adair · Director
  • Jan Garfinkle · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On a merger: “Issued in connection with and pursuant to a letter agreement related to an Agreement and Plan of Merger under which the Issuer was formed.”

Signed by Michael Kujak, President and Chief Executive Officer. Newest notice filed Nov 29, 2018 (1 amendment). Read the notice at the SEC.

equitySEC

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • NxPHASE Medical, Inc. chose not to state its revenue in its newest notice of a funding round (Dec 2024).

    SEC Form D · Dec 2024

  • The industry group it chose in its notices: Other Health Care.

    SEC Form D · Dec 2024

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of NxPHASE Medical, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by NxPHASE Medical, Inc.
NameRoleNamed in
Michael KujakExecutive officerDec 2024
Michael HoeyExecutive officerNov 2018
Andre de BruinDirectorDec 2024
Andrew CleelandDirectorDec 2024
David AdairDirectorDec 2024
Jan GarfinkleDirectorDec 2024
Michael HoeyDirectorDec 2024
Michael KujakDirectorDec 2024